Local Shear Conditions and Platelet Aggregates Regulate the Incorporation and Activity of Circulating Tissue Factor in ex-vivo Thrombi

Summary

The presence of thrombogenic blood-borne or circulating tissue factor (cTF) has recently been demonstrated. These observations have implicated cTF to be a key determinant of thrombus propagation by depositing on platelets in nascent thrombi. Previously, we detected cTF by detergent solubilization and addition of phospholipids. We now report the direct demonstration of TF activity in ex-vivo thrombi. Collagen-coated substrates were exposed to native blood at shear rates of 0, 650, and 2000 s^-1 for 10 min in a modified rotating Teflon cone and plate viscometer. Substrates were then gently rinsed to remove ‘loose’ (unadherent) components of blood. cTF activity was measured by adding a solution containing 10 nM FVIIa, 100 nM FX, and 5 mM CaCl2 to the substrates exposed to blood. Samples of this mixture were obtained at intervals for 30 min and the amount of Xa generated was quantified by adding a chromogenic substrate, Spectrozyme Xa, and measuring the increase in OD at 405 nm. Our studies show that a minimal amount of generated Xa (∼ 1nM) can be measured from ex-vivo thrombi. Static and shear samples generated the same amount of Xa, with the exception of blood subjected to 650 s^-1 shear. At 650 s^-1 shear rate, the amount of Xa generated reached a maximum of 4 nM at 5 min and then decreased to ∼1 nM. Immunohistological stains and fluorescent images demonstrate the presence of cTF antigen at 650 s^-1 wall shear rate.

Keywords

Blood-borne tissue factor - platelets - thrombus - shear

• References

• 1 Zeldis SM, Nemerson Y, Pitlick FA, Lentz TL. Tissue factor (thromboplastin): localization to plasma membranes by peroxidase-conjugated antibodies. Science 1972; 175: 766-8.
• 2 Nemerson Y. Tissue Factor: Then and Now. Thromb Haemost 1995; 74: 180-4.
• 3 Giesen PL, Rauch U, Bohrmann B, Kling D, Roque M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-5.
• 4 Rauch U, Bonderman D, Bohrmann B, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 2000; 96: 170-5.
• 5 Soejima H, Ogawa H, Yasue H, Nishiyama K, Kaikita K, Misumi K, Takazoe K, Kugiyama K, Tsuji I, Kumeda K, Nakamura S. Plasma tissue factor pathway inhibitor and tissue factor antigen levels after administration of heparin in patients with angina pectoris. Thromb Res 1999; 93: 17-25.
• 6 Suefuji H, Ogawa H, Yasue H, Kaikita K, Soejima H, Motoyama T, Mizuno Y, Oshima S, Saito T, Tsuji I, Kumeda K, Kamikubo Y, Nakamura S. Increased plasma tissue factor levels in acute myocardial infarction. Am Heart J 1997; 134: 253-9.
• 7 Gando S, Nanzaki S, Sasaki S, Aoi K, Kemmotsu O. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Crit Care Med 1998; 26: 2005-9.
• 8 Asakura H, Kamikubo Y, Goto A, Shiratori Y, Yamazaki M, Jokaji H, Saito M, Uotani C, Kumabashiri IE. Morishita aea. Role of tissue factor in disseminated intravascular coagulation. Thromb Res 1995; 80: 217-24.
• 9 Amengual O, Atsumi T, Khamashta MA, Hughes GR. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemost 1998; 79: 276-81.
• 10 Carey MJ, Rodgers GM. Disseminated intravascular coagulation: clinical and laboratory aspects. Am J Hematol 1998; 59: 65-73.
• 11 Key NS, Slungaard A, Dandelet L, Nelson SC, Moertel C, Styles LA, Kuypers FA, Bach RR. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood 1998; 91: 4216-23.
• 12 Albrecht S, Kotzsch M, Siegert G, Luther T, Grossmann H, Grosser M, Muller M. Detection of circulating tissue factor and factor VII in a normal population. Thromb Haemost 1996; 75: 772-7.
• 13 Bach RR, Moldow CF. Mechanism of Tissue Factor Activation on HL-60 Cells. Blood 1997; 89 (09) 3270-6.
• 14 Miletich JP, Broze GJ, Majerus PW. Purification of human coagulation factors II, IX and X using sulfated dextran beads. Methods Enzymol 1981; 80: 221-8.
• 15 Carson SD, Ross SE, Bach R, Guha A. An inhibitory monoclonal antibody against human tissue factor. Blood 1987; 70: 490-493.
• 16 Carson SD, Bromberg ME. Tissue Factor Encryption/de-encryption is not Altered in the Absence of theCytoplasmic Domain. Thromb Haemost 2000; 84: 657-63.
• 17 Wolberg AS, Kon RH, Monroe DM, Ezban M, Roberts HR, Hoffman M. Deencryption of cellular tissue factor is independent of its cytoplasmic domain. Biochem Biophys Res Commun 2000; 272: 332-6.
• 18 Swords NA, Mann KG. The assembly of the prothrombinase complex on adherent platelets. Arterioscle. Thromb 1993; 13: 1602-12.
• 19 Wolberg AS, Monroe DM, Hoffman MR. Tissue factor de-encryption: ionophore treatments induces changes in tissue factor activity by phophotidylserine -dependent and -independent mechanisms. Blood Coagul Fibrinolysis 1999; 10: 201-10.
• 20 Greeno EW, Bach RR, Moldow CF. Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest 1996; 75: 281-9.
• 21 Turitto VT, Muggli R, Baumgartner HR. Physical factors influencing platelet deposition on subendothelium: Importance of blood shear rate. Annals of the New York Academy of Sciences 1977; 183: 284-93.